NARA Discovery
Article Details
← Back to Search Results
Journal Article

Clinical features and potential markers of disease in idiopathic non-histaminergic angioedema, a real-life study

Ilaria Mormile; Maria Celeste Gigliotti; Anne Lise Ferrara; Roberta Gatti; Giuseppe Spadaro; Amato de Paulis; Stefania Loffredo; Maria Bova; Angelica Petraroli
Immunologic Research · Vol. 72, Issue 5 · pp. 991-1002 · 2024

Abstract

Idiopathic non-histaminergic acquired angioedema (InH-AAE) is a rare disease, with unknown etiology and pathogenesis, characterized by recurrent clinical manifestations and resistance to antihistamines and corticosteroids. We aim to evaluate clinical features and potential markers of disease in an Italian cohort of patients with InH-AAE. We enrolled 26 patients diagnosed with InH-AAE. Information about clinical features, treatments, routine laboratory investigations, immunological and genetic tests were collected. We assessed plasma levels of complement components, angiogenic and lymphangiogenic mediators, proinflammatory cytokines and chemokines, and activity of phospholipases A2. Finally, patients underwent nailfold videocapillaroscopy (NVC); both quantitative and qualitative capillaroscopic parameters were analyzed. Plasma levels of VEGFs were similar in healthy controls and in InH-AAE patients. ANGPT1 was decreased in InH-AAE patients compared to controls while ANGPT2 was similar to controls. Interestingly, the ANGPT2/ANGPT1 ratio (an index of vascular permeability) was increased in InH-AAE patients compared to controls. sPLA2 activity, elevated in patients with C1-INH-HAE, showed differences also when measured in InH-AAE patients. TNF-α concentration was higher in InH-AAE patients than in healthy controls, conversely, the levels of CXCL8, and IL-6 were similar in both groups. At the NVC, the capillary loops mainly appeared short and tortuous in InH-AAE patients. InH-AAE represents a diagnostic challenge. Due to the potential life-threatening character of this condition, a prompt identification of the potentially bradykinin-mediated forms is crucial. A better comprehension of the mechanism involved in InH-AAE would also lead to the development of new therapeutic approaches to improve life quality of patients affected by this disabling disease.

Bibliographic Information

JournalImmunologic Research
PublisherSpringer
Publication Date2024-10-01
Publication Year2024
Volume72
Issue5
Pages991-1002
Document TypeJournal Article
eISSN1559-0755
DOI10.1007/s12026-024-09501-9

Access Information

NARA Access Coverage1982-01-01~Current
Journal Homepagehttps://www.springer.com/journal/12026
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.